Search

You searched for "Suturing"

1893 results found
Ophthalmologica journal cover image.

Intravitreal dexamethasone in diabetic macular oedema (DMO) - enhancing the response to anti-VEGF in non- or poor responders

3 February 2023 | | EYE - Vitreo-Retinal | Aflibercept, Anti-VEGF, Dexamethasone implant, Diabetic macular oedema, Persistent, Ranibizumab, Resistant
This study aimed to describe the outcomes of a switch back from DEXi (dexamethasone implant) to anti-VEGF therapy in eyes that were treated temporarily with DEXi after an initial poor response to anti VEGF. Twenty-three eyes of 17 patients were...

Evisceration in India: demographic and clinical trends from a large multicentre cohort study

4 October 2023 | | EYE - Orbit
In this multicentre cohort study, the authors investigated a total of 2071 patients who underwent evisceration with primary implant placement over a six-year period at four tertiary eyecare centres in India. Out of 1,345,480 new ophthalmic presentations during the study...

Surgitrac Instruments at the 43rd Congress of the ESCRS: A Successful Event in Copenhagen

22 September 2025 | Company Profiles, Awards, Conferences & Anniversaries
Surgitrac Instruments was proud to exhibit at the 43rd Congress of the ESCRS in the beautiful city of Copenhagen. This year’s congress was a fantastic opportunity to connect with ophthalmic professionals from around the world, share ideas, and showcase our...

Surgitrac Offers Free 2 Week Trial on Ophthalmic Operating Tables

30 March 2026 | Company Profiles, Research & Development
Surgitrac Instruments is proud to offer a free 2-week trial of its advanced ophthalmic operating solutions. This exclusive opportunity is ideal for NHS and private clinics, ophthalmic surgeons, theatre teams, and procurement professionals looking to enhance surgical performance and patient...

Moorfields: Implementing a non-medical intravitreal injection service Nov

13 November 2025
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services.

RCOphth Back to Basics - Byte sized topics for all

22 October 2025
The Royal College of Ophthalmologists Back to Basics - Byte sized topics for all

Moorfields: Implementing a non-medical intravitreal injection service

4 July 2025
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services. With an increasing demand in treatment for people with eye conditions such as...

Moorfields implementing a non-medical intravitreal injection service

28 March 2025
This highly sought after intravitreal injection course has had a national and global impact by enabling numerous institutions to establish their own non-medical delivered IVT injection services. With an increasing demand in treatment for people with eye conditions such as...

Time is vision in central retinal artery occlusion

4 August 2021 | | EYE - Vitreo-Retinal, EYE - General
Central retinal artery occlusion (CRAO) is a rare but devastating vascular episode that can have severe impact on vision. Treatment is very time-limited and needs to be initiated very quickly to salvage any vision. The majority of patients present to...

The ocular manifestations of COVID-19: an overview of current literature

6 April 2021 | | EYE - Cornea, EYE - Vitreo-Retinal, EYE - Neuro-ophthalmology
Although respiratory symptoms are the most frequent manifestation of COVID-19, multi-organ involvement has been demonstrated, including ocular manifestations. The author investigates how the eye can be affected. The SARS-CoV-2 virus responsible for the COVID-19 pandemic has presented a significant public...

Management of a giant pigment epithelium detachment with transition from half- to full-dose aflibercept

2 March 2026 | | EYE - Imaging, EYE - Vitreo-Retinal
This case report describes the management of a giant pigment epithelial detachment (PED) in neovascular age-related macular degeneration (nAMD) using half-dose aflibercept. An 80-year-old woman presented with a huge PED (maximum height 1338µm) and multiple risk factors for retinal pigment...

Life’s rich tapestry

2 February 2024 |
Have you ever watched someone cross-stitch, or do needle-point? I recently had the joy of observing my teenage daughter create such an artwork. She separated all the threads into the various colours, and then started to follow the instructions carefully....